115 related articles for article (PubMed ID: 30982574)
1. Fucoxanthin exerts anti-fibrogenic effects in hepatic stellate cells.
Kim MB; Bae M; Hu S; Kang H; Park YK; Lee JY
Biochem Biophys Res Commun; 2019 Jun; 513(3):657-662. PubMed ID: 30982574
[TBL] [Abstract][Full Text] [Related]
2. Astaxanthin prevents TGFβ1-induced pro-fibrogenic gene expression by inhibiting Smad3 activation in hepatic stellate cells.
Yang Y; Kim B; Park YK; Koo SI; Lee JY
Biochim Biophys Acta; 2015 Jan; 1850(1):178-85. PubMed ID: 25450180
[TBL] [Abstract][Full Text] [Related]
3. Sauchinone attenuates liver fibrosis and hepatic stellate cell activation through TGF-β/Smad signaling pathway.
Lee JH; Jang EJ; Seo HL; Ku SK; Lee JR; Shin SS; Park SD; Kim SC; Kim YW
Chem Biol Interact; 2014 Dec; 224():58-67. PubMed ID: 25451574
[TBL] [Abstract][Full Text] [Related]
4. Clonorchis sinensis lysophospholipase inhibits TGF-β1-induced expression of pro-fibrogenic genes through attenuating the activations of Smad3, JNK2, and ERK1/2 in hepatic stellate cell line LX-2.
Zhou L; Shang M; Shi M; Zhao L; Lin Z; Chen T; Wu Y; Tang Z; Sun H; Yu J; Huang Y; Yu X
Parasitol Res; 2016 Feb; 115(2):643-50. PubMed ID: 26486942
[TBL] [Abstract][Full Text] [Related]
5. Fucoxanthin Attenuates the Reprogramming of Energy Metabolism during the Activation of Hepatic Stellate Cells.
Bae M; Kim MB; Lee JY
Nutrients; 2022 May; 14(9):. PubMed ID: 35565869
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Carotenoids for Their Antifibrogenic Effects in Hepatic Stellate Cells.
Bae M; Kim MB; Kang H; Park YK; Lee JY
Lipids; 2019 Jun; 54(6-7):401-410. PubMed ID: 31140624
[TBL] [Abstract][Full Text] [Related]
7. Ampelopsin attenuates carbon tetrachloride-induced mouse liver fibrosis and hepatic stellate cell activation associated with the SIRT1/TGF-β1/Smad3 and autophagy pathway.
Ma JQ; Sun YZ; Ming QL; Tian ZK; Yang HX; Liu CM
Int Immunopharmacol; 2019 Dec; 77():105984. PubMed ID: 31677501
[TBL] [Abstract][Full Text] [Related]
8. NLRC5 regulates TGF-β1-induced proliferation and activation of hepatic stellate cells during hepatic fibrosis.
Xu T; Ni MM; Xing-Li ; Li XF; Meng XM; Huang C; Li J
Int J Biochem Cell Biol; 2016 Jan; 70():92-104. PubMed ID: 26592197
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase 9 plays a role in the antifibrogenic effect of astaxanthin in hepatic stellate cells.
Yang Y; Bae M; Park YK; Lee Y; Pham TX; Rudraiah S; Manautou J; Koo SI; Lee JY
J Nutr Biochem; 2017 Feb; 40():172-177. PubMed ID: 27915160
[TBL] [Abstract][Full Text] [Related]
10. n-3 PUFAs inhibit TGFβ1-induced profibrogenic gene expression by ameliorating the repression of PPARγ in hepatic stellate cells.
Hu S; Bae M; Park YK; Lee JY
J Nutr Biochem; 2020 Nov; 85():108452. PubMed ID: 32745880
[TBL] [Abstract][Full Text] [Related]
11. Hepcidin inhibits Smad3 phosphorylation in hepatic stellate cells by impeding ferroportin-mediated regulation of Akt.
Han CY; Koo JH; Kim SH; Gardenghi S; Rivella S; Strnad P; Hwang SJ; Kim SG
Nat Commun; 2016 Dec; 7():13817. PubMed ID: 28004654
[TBL] [Abstract][Full Text] [Related]
12. Nicotinamide riboside protects against liver fibrosis induced by CCl
Jiang R; Zhou Y; Wang S; Pang N; Huang Y; Ye M; Wan T; Qiu Y; Pei L; Jiang X; Huang Y; Yang H; Ling W; Li X; Zhang Z; Yang L
Life Sci; 2019 May; 225():20-28. PubMed ID: 30928408
[TBL] [Abstract][Full Text] [Related]
13. Interaction between insulin-like growth factor binding protein-related protein 1 and transforming growth factor beta 1 in primary hepatic stellate cells.
Li XQ; Zhang QQ; Zhang HY; Guo XH; Fan HQ; Liu LX
Hepatobiliary Pancreat Dis Int; 2017 Aug; 16(4):395-404. PubMed ID: 28823370
[TBL] [Abstract][Full Text] [Related]
14. Metformin ameliorates activation of hepatic stellate cells and hepatic fibrosis by succinate and GPR91 inhibition.
Nguyen G; Park SY; Le CT; Park WS; Choi DH; Cho EH
Biochem Biophys Res Commun; 2018 Jan; 495(4):2649-2656. PubMed ID: 29278707
[TBL] [Abstract][Full Text] [Related]
15. ASPP2 Inhibits the Profibrotic Effects of Transforming Growth Factor-β1 in Hepatic Stellate Cells by Reducing Autophagy.
Lin M; Chang Y; Xie F; Shi Y; Pang L; Chen D
Dig Dis Sci; 2018 Jan; 63(1):146-154. PubMed ID: 29196956
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of eIF3a attenuates the pro-fibrogenic response of hepatic stellate cells induced by TGF-β1.
He P; Yu ZJ; Sun CY; Jiao SJ; Jiang HQ
Cell Mol Biol (Noisy-le-grand); 2016 May; 62(6):107-11. PubMed ID: 27262813
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of LOXL1 inhibits TGF-β1-induced proliferation and fibrogenesis of hepatic stellate cells by inhibition of Smad2/3 phosphorylation.
Ma L; Zeng Y; Wei J; Yang D; Ding G; Liu J; Shang J; Kang Y; Ji X
Biomed Pharmacother; 2018 Nov; 107():1728-1735. PubMed ID: 30257391
[TBL] [Abstract][Full Text] [Related]
18. Reactive oxygen species and NADPH oxidase 4 induced by transforming growth factor β1 are the therapeutic targets of polyenylphosphatidylcholine in the suppression of human hepatic stellate cell activation.
Ikeda R; Ishii K; Hoshikawa Y; Azumi J; Arakaki Y; Yasui T; Matsuura S; Matsumi Y; Kono Y; Mizuta Y; Kurimasa A; Hisatome I; Friedman SL; Kawasaki H; Shiota G
Inflamm Res; 2011 Jun; 60(6):597-604. PubMed ID: 21318733
[TBL] [Abstract][Full Text] [Related]
19. Fibronectin Type III Domain-Containing 5 Attenuates Liver Fibrosis Via Inhibition of Hepatic Stellate Cell Activation.
Zhou B; Ling L; Zhang F; Liu TY; Zhou H; Qi XH; Chen Q; Li YH; Kang YM; Zhu GQ
Cell Physiol Biochem; 2018; 48(1):227-236. PubMed ID: 30007970
[TBL] [Abstract][Full Text] [Related]
20. Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-β1/Smads signaling pathway modulation.
Zhou Y; Tong X; Ren S; Wang X; Chen J; Mu Y; Sun M; Chen G; Zhang H; Liu P
J Ethnopharmacol; 2016 Aug; 190():83-90. PubMed ID: 27282665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
